Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
Get the latest updates from ClinicalTrials.gov: Tirzepatide OR Mounjaro OR LY3298176 OR Retatrutide OR LY3437943 OR LY3502970 OR orforglipron OR Mazdutide OR LY3305677 OR IBI362 OR semaglutide OR CagriSema OR Amycretin OR XW004 OR XW014 OR XW010 OR XW003 OR XW013 OR XW015 OR AMG133 directly as they happen.
Follow now < 10 followers
Last updated 1 day ago
3 days ago
Conditions: Type 2 Diabetes; Overweight; Cardiovascular (CV) Risk Interventions: Drug: Tirzepatide; Drug...
3 days ago
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: New use of semaglutide injection...
3 days ago
Conditions: Type 2 Diabetes; Major Adverse Cardiac Events; Cardiovascular (CV) Risk Interventions...
3 days ago
Conditions: Obesity; Overweight Interventions: Drug: Tirzepatide; Drug: LY3841136; Drug: Placebo Sponsors: Eli...
3 days ago
Conditions: Obesity; Overweight Interventions: Drug: LY3305677; Drug: LY3841136; Drug: Tirzepatide; Drug: Placebo...
4 days ago
Conditions: Obesity & Overweight Sponsors: Closed Loop Medicine Recruiting
4 days ago
Conditions: Alcohol Use Disorder; Obesity and Overweight; Alcohol Interventions: Drug: Tirzepatide; Drug...
4 days ago
Conditions: Prostate Carcinoma; Recurrent Prostate Carcinoma Interventions: Drug: Antiandrogen Therapy; Behavioral: Behavioral...
4 days ago
Conditions: Obesity and Overweight; Appetite Regulation Interventions: Drug: Dichrostachys glomerata; Drug: Cissus...
4 days ago
Conditions: Endometrial Cancer Interventions: Drug: Tirzepatide Sponsors: Memorial Sloan Kettering Cancer Center...
9 days ago
Conditions: Crohn's Disease; Obesity or Overweight Interventions: Drug: Mirikizumab; Drug: Mirikizumab; Drug...
9 days ago
Conditions: Obesity; Overweight Interventions: Drug: Orforglipron; Drug: Placebo Sponsors: Eli Lilly and...